# Tenofovir in Chronic Hepatitis B With Mild ALT Elevation

> **NCT01522625** · PHASE4 · COMPLETED · sponsor: **E-DA Hospital** · enrollment: 160 (actual)

## Conditions studied

- Chronic Hepatitis B

## Interventions

- **DRUG:** tenofovir disoproxil fumarate 300mg per day
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01522625
- **Lead sponsor:** E-DA Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2018-11
- **Final completion:** 2018-12
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2019-02-12

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01522625

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01522625, "Tenofovir in Chronic Hepatitis B With Mild ALT Elevation". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01522625. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*